12:07 PM EST - Acerus Pharmaceuticals Corporation : Today reported its financial results for the three-month period ended March 31, 2019. Unless otherwise noted, all amounts are in U.S. dollars and are prepared in accordance with International Financial Reporting Standards Total Q1 2019 revenue was $2.2 million compared with $1.6 million of revenue in Q1-2018. The Company incurred a net loss of $4.4 million or $(0.02) per share for the quarter compared to a loss of $4.5 million or $(0.02) per share for the first quarter of 2018. Acerus Pharmaceuticals Corporation
T.ASP
shares T.ASP are trading down $0.01 at $0.16.
